Live feed07:00:00·162dPRReleasevia QuantisnowRezolute Provides Update on its Congenital Hyperinsulinism Program Following FDA MeetingByQuantisnow·Wall Street's wire, on your screen.RZLT· Rezolute Inc.Health Care
